Related Experiment Video
Updated: Aug 16, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease
Leslie J Raffini1, Alison E Niebanck, Joanne Hrusovsky
1Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, and Duke University School of Medicine, Durham, NC, USA. raffini@email.chop.edu
Insights
Children with sickle cell disease (SCD) often have prolonged prothrombin times (PTs) before surgery. Abnormal coagulation screening tests in SCD patients may indicate bleeding risks, warranting further investigation.
Area of Science:
- Hematology
- Pediatric Surgery
- Coagulation Disorders
Background:
- Sickle cell disease (SCD) is associated with increased perioperative complications, particularly bleeding.
- Understanding coagulation abnormalities in pediatric SCD patients is crucial for surgical risk assessment.
Purpose of the Study:
- To determine the prevalence of abnormal coagulation screening tests in pediatric patients with SCD.
- To evaluate potential etiologies for these coagulation abnormalities.
- To assess the association between prolonged PTs and perioperative bleeding in SCD.
Main Methods:
- Retrospective review of pre-operative coagulation studies in pediatric SCD patients.
- Prospective study of 100 well children with SCD to assess coagulation parameters.
- Analysis of prothrombin time (PT) and activated partial thromboplastin time (aPTT) results.
- Evaluation of coagulation factor levels (Factor V, VII) and vitamin K status.
Main Results:
- 38.1% of retrospective SCD patients had prolonged PTs; 8% in the prospective study.
- Prolonged PTs in prospective SCD patients correlated with lower Factor V and VII levels.
- Factor VII levels were significantly lower in SCD patients with prolonged PTs (P=0.001).
- Six of seven SCD children with prolonged PTs experienced significant intraoperative blood loss (P=0.04).
Conclusions:
- Pediatric SCD patients undergoing surgery are more likely to exhibit prolonged PTs compared to healthy controls.
- Coagulation abnormalities in SCD may stem from clinical status, liver dysfunction, or factor consumption.
- Further prospective studies are needed to confirm the link between abnormal coagulation tests and perioperative bleeding risk in pediatric SCD.
Background:
Patients with sickle cell disease (SCD) have high rates of perioperative complications, including bleeding 1,2.
Procedures:
We conducted a retrospective review of pre-operative coagulation studies in pediatric patients with SCD followed by a prospective study of 100 well children with SCD to determine the prevalence of abnormal coagulation screening tests, and to evaluate potential etiologies.
Results:
In the retrospective study, 32/84 (38.1%) had a prolonged prothrombin time (PT), compared to 8/100 in the prospective study. Prolongations of the activated partial thromboplastin time (aPTT) were less common. Children in the prospective study with prolonged PTs had significantly lower levels of Factor V and VII compared to those with normal PTs. Factor VII levels were <50% in 4/8 with long PTs, compared to 3/92 with normal PTs, P=0.001. Though retrospectively, several patients had normalization of their PT with vitamin K, there was no laboratory evidence of vitamin K deficiency in the prospective study. In the retrospective analysis, six of seven children who had pre-operative coagulation studies and significant intraoperative blood loss had prolonged PTs (P=0.04).
Conclusions:
Children with SCD admitted for surgical procedures were more likely to have prolonged PTs than those tested at a well visit. There was intra-patient variability in coagulation studies that may be related to clinical status, hepatocellular dysfunction, and/or increased clotting factor consumption. Future well-designed prospective studies to determine whether abnormal coagulation studies are associated with an increased risk of perioperative bleeding in children with SCD are necessary.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
